Literature DB >> 16161190

Rationing and competition in the Dutch health-care system.

Frederik T Schut1, Wynand P M M Van de Ven.   

Abstract

In this paper we examine the goals and effects of health-care policy in the Netherlands over the period 1980--2000. During this period Dutch health-care policy is marked by a peculiar combination of increasingly stringent cost-containment policies alongside a persistent pursuit of market-oriented reforms. The main goal of cost containment was to keep labour costs down under the restriction of universal equal access to health care. Supply and price control policies were quite successful in achieving cost containment, but in due course prolonged quantity rationing began to jeopardise universal physical access to health services. The main goal of market-oriented health-care reforms is to increase the system's efficiency and its responsiveness to patient's needs, while maintaining equal access. The feasibility of the reforms crucially hinges on the realisation of adequate methods of risk adjustment, product classification and quality measurement, an appropriate consumer information system and an effective competition policy. Realising these preconditions requires a lengthy and cautious implementation process. Although considerable progress has been made in setting the appropriate stage for regulated competition in Dutch health care, the role of the market is still limited. Copyright (c) 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2005        PMID: 16161190     DOI: 10.1002/hec.1036

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  18 in total

Review 1.  Public release of performance data in changing the behaviour of healthcare consumers, professionals or organisations.

Authors:  Nicole A B M Ketelaar; Marjan J Faber; Signe Flottorp; Liv Helen Rygh; Katherine H O Deane; Martin P Eccles
Journal:  Cochrane Database Syst Rev       Date:  2011-11-09

2.  When Time is Not on Your Side: Patient Experiences with Waiting for Home Care and Admission to a Nursing or Residential Home.

Authors:  N Job A van Exel; Marion de Ruiter; Werner B F Brouwer
Journal:  Patient       Date:  2008-01-01       Impact factor: 3.883

3.  Why do patients bypass the nearest hospital? An empirical analysis for orthopaedic care and neurosurgery in the Netherlands.

Authors:  Marco Varkevisser; Stéphanie A van der Geest
Journal:  Eur J Health Econ       Date:  2007-01-26

4.  Building a competitive insurance system: Switzerland's strategy for managed-care healthcare.

Authors:  Peter Zweifel
Journal:  Pharmacoeconomics       Date:  2006-12       Impact factor: 4.981

5.  Choice of insurer for basic health insurance restricted by supplementary insurance.

Authors:  Daniëlle M I D Duijmelinck; Wynand P M M van de Ven
Journal:  Eur J Health Econ       Date:  2013-07-26

6.  Assessing hospital competition when prices don't matter to patients: the use of time-elasticities.

Authors:  Marco Varkevisser; Stéphanie A van der Geest; Frederik T Schut
Journal:  Int J Health Care Finance Econ       Date:  2009-08-07

7.  Patient hospital choice for hip replacement: empirical evidence from the Netherlands.

Authors:  Puck D C Beukers; Ron G M Kemp; Marco Varkevisser
Journal:  Eur J Health Econ       Date:  2013-10-25

8.  Healthcare costs and obesity prevention: drug costs and other sector-specific consequences.

Authors:  David R Rappange; Werner B F Brouwer; Rudolf T Hoogenveen; Pieter H M Van Baal
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

9.  A comparison of a postal survey and mixed-mode survey using a questionnaire on patients' experiences with breast care.

Authors:  Marloes Zuidgeest; Michelle Hendriks; Laura Koopman; Peter Spreeuwenberg; Jany Rademakers
Journal:  J Med Internet Res       Date:  2011-09-27       Impact factor: 5.428

Review 10.  Impact of public release of performance data on the behaviour of healthcare consumers and providers.

Authors:  David Metcalfe; Arturo J Rios Diaz; Olubode A Olufajo; M Sofia Massa; Nicole Abm Ketelaar; Signe A Flottorp; Daniel C Perry
Journal:  Cochrane Database Syst Rev       Date:  2018-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.